Sponsor:
Weill Medical College of Cornell University
Code:
NCT03063554
Conditions
Pancreatic Cancer
Pancreatic Adenocarcinoma
Biliary Tract Neoplasms
Biliary Duct Obstruction
Unresectable Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Endoscopic Ultrasound Guided Biliary Drainage
ERCP
Brief summary:
Conditions
Pancreatic Cancer
Pancreatic Adenocarcinoma
Biliary Tract Neoplasms
Biliary Duct Obstruction
Unresectable Pancreatic Cancer
Study ID
NCT03063554
Start date
Oct 18, 2016
Status verified date
Feb, 2017
Completion date
Oct 1, 2018
Anticipated
Primary completion date
Sep 1, 2018
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Endoscopic Ultrasound Guided Biliary Drainage
placebo comparator: ERCP
Interventions
Endoscopic Ultrasound Guided Biliary Drainage
ERCP
Primary outcome measure
Central contacts
Locations
Weill Cornell Medical College
Recruiting
New York, New York, United States, 10065
Contacts
Sponsor
Weill Medical College of Cornell University
Last update posted
Feb 24, 2017
Last verified
Feb, 2017
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2017-02-24.